Table 3

Mean reaction times and standard deviations (in milliseconds) for each substance, condition and target type separately*

Group; mean RT ± SDANOVA results
Substance; conditionDominantSubordinateEffect/interactionFp valueDirection/post hoc
SOA of 150 ms
HaloperidolTarget type4.960.033Dominant < subordinate linear F = 4.74, p = 0.037
Condition3.170.049
 Congruent464.86 ± 67.4480.39 ± 61.5
 Incongruent483.68 ± 76.3488.40 ± 65.0
 Unbiased481.08 ± 56.5494.46 ± 59.5
L-DopaTarget type0.480.49Linear F = 6.48, p = 0.016
Condition3.040.06
 Congruent485.54 ± 71.3486.43 ± 68.8
 Incongruent463.70 ± 67.6473.37 ± 69.9
 Unbiased474.93 ± 64.1475.87 ± 82.1
PlaceboTarget type2.550.12Dominant < subordinate
Condition0.730.49
 Congruent478.17 ± 51.5483.88 ± 55.1
 Incongruent470.28 ± 58.0490.63 ± 70.3
 Unbiased470.48 ± 61.6474.45 ± 67.7
SOA of 750 ms
HaloperidolTarget type3.890.06Subordinate < dominant
Condition0.020.98
 Unbiased442.65 ± 99.7428.86 ± 76.2
 Congruent442.52 ± 105.6431.84 ± 83.4
 Incongruent437.81 ± 70.0421.36 ± 69.1
L-DopaTarget type1.030.32
Condition0.610.56
 Unbiased425.19 ± 86.2417.48 ± 76.9
 Congruent425.75 ± 86.6423.20 ± 63.5
 Incongruent425.81 ± 82.0422.10 ± 103.9
PlaceboTarget type0.010.98Linear F = 3.30, p = 0.08
Condition1.190.31
 Unbiased429.13 ± 79.0446.42 ± 116.6
 Congruent429.86 ± 78.46422.49 ± 62.4
 Incongruent440.18 ± 86.88440.24 ± 70.2
  • ANOVA = analysis of variance; L-Dopa = levodopa; RT = reaction time; SD = standard deviation; SOA = stimulus onset asynchronies.

  • * Results of 3 (condition) × 2 (target type) ANOVAs on RTs for each substance separately are presented. Target type × condition interactions are not displayed because they were not significant in any case (all p > 0.4).